A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
- Status
- RECRUITING
- Phase
- PHASE3
Related studies linked through entity extraction aliases.